Supplement Imports From Canada, UK Detained: Health And Wellness Industry News
This article was originally published in The Rose Sheet
Executive Summary
Mannatech Q1 sales flat; Natural Alternatives slowed by Asia, Europe dips; and four Canadian firms and one UK business are among the supplement importers with products detained at US ports so far in 2017 due to drug claims.
You may also be interested in...
Recipe For An FDA Warning In Nutritional Designs' Medical Food Claims
Medical foods "are not those simply recommended by a physician as part of an overall diet to manage the symptoms, or reduce the risk of a disease or condition," FDA says. The agency also halts imports of Canadian firm NuEra Nutraceutials' ginseng and herbal soap.
Aloe Drug Claims Land Indian Firm On FDA Import Alert List
The June 2 update to FDA's list of businesses and their products banned from import also increases the number of Canadian firms identified during 2017 as shipping supplement products that make drug claims or that were made in facilities out of compliance with the agency's good manufacturing practices regulations.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.